hkr.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Neutralizing Ljungan virus antibodies in children with newly diagnosed type 1 diabetes
Lunds universitet, CRC.
USA.
Lunds universitet, CRC.
USA.
Show others and affiliations
2021 (English)In: Journal of General Virology, ISSN 0022-1317, E-ISSN 1465-2099, Vol. 102, no 5Article in journal (Refereed) Published
Abstract [en]

Ljungan virus (LV), a Parechovirus of the Picornavirus family, first isolated from a bank vole at the Ljungan river in Sweden, has been implicated in the risk for autoimmune type 1 diabetes. An assay for neutralizing Ljungan virus antibodies (NLVA) was developed using the original 87-012 LV isolate. The goal was to determine NLVA titres in incident 0-18 years old newly diagnosed type 1 diabetes patients (n=67) and school children controls (n=292) from Jämtland county in Sweden. NLVA were found in 41 of 67 (61 %) patients compared to 127 of 292 (44 %) controls (P=0.009). In the type 1 diabetes patients, NLVA titres were associated with autoantibodies to glutamic acid decarboxylase (GADA) (P=0.023), but not to autoantibodies against insulin (IAA) or islet antigen-2 (IA-2A). The NLVA assay should prove useful for further investigations to determine levels of LV antibodies in patients and future studies to determine a possible role of LV in autoimmune type 1 diabetes.

Place, publisher, year, edition, pages
2021. Vol. 102, no 5
Keywords [en]
Ljungan Virus, Type 1 diabetes, beta cell autoimmunity, glutamic acid decarboxylase autoantibodies, human pathogen, neutralization assay
National Category
Endocrinology and Diabetes Infectious Medicine
Identifiers
URN: urn:nbn:se:hkr:diva-21920DOI: 10.1099/jgv.0.001602ISI: 000659946800007PubMedID: 34020728OAI: oai:DiVA.org:hkr-21920DiVA, id: diva2:1558248
Funder
Ernfors FoundationStiftelsen Olle Engkvist ByggmästareDiabetesfonden
Note

Erratum: Neutralizing Ljungan virus antibodies in children with newly diagnosed type 1 diabetes, Annika Lundstig, Sharla L. McDonald, Marlena Maziarz, William C. Weldon, Fariba Vaziri-Sani, Åke Lernmark and Anna-Lena Nilsson, Journal of General Virology 2021;102, doi: 10.1099/jgv.0.001602

In the published version of this article, the second author’s name was listed incorrectly. The author’s name should have been listed as: ‘Sharla L. McDonald’.

The Microbiology Society apologises for any inconvenience caused.

Funding information:

This study was supported by the:

Stiftelsen Axel Tielmans MinnesfondPrinciple Award Recipient: Annika Lundstig

H.K.H. Kronprinsessan Lovisas Förening för Barnasjukvård (SE)Principle Award Recipient: Annika Lundstig

Sven Mattssons Stiftelse Principle Award Recipient: Annika Lundstig

Lunds Revisorer Principle Award Recipient: Annika Lundstig

Lisa och Johan Grönbergs StiftelsePrinciple Award Recipient: Annika Lundstig

Sydvästra Skånes Diabetesförening Principle Award Recipient: Annika Lundstig

Available from: 2021-05-28 Created: 2021-05-28 Last updated: 2021-09-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedhttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.001602
By organisation
Faculty of Health Science
In the same journal
Journal of General Virology
Endocrinology and DiabetesInfectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 40 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf